Andere Sprachen Glenmark Pharmaceuticals Limited

Aktien

A0MU6U

INE935A01035

GLENMARK

Markt geschlossen - NSE India S.E. Andere Börsenplätze 13:43:48 02.05.2024			% 5 Tage	% 1. Jan.
1’060 ^INR	+0.31%		+2.51%	+24.19%

29.04.	Glenmark Pharmaceuticals erhält endgültige Zulassung der US FDA für generische Schmerzmittel	MT
25.04.	Nettogewinn von Glenmark Lifesciences im 4. Quartal des Geschäftsjahres gesunken	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines	29.04.
Glenmark Lifesciences' Net Profit Slides in Fiscal Q4	25.04.
Glenmark Pharmaceuticals Limited Announces Board Changes	01.04.
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	12.03.
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	15.02.
Indian shares set to open higher	15.02.
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	14.02.
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14.02.
Glenmark Pharma, Pfizer Launch Atopic Dermatitis Oral Treatment in India	01.02.
Indian shares set to open higher ahead of national budget	01.02.
Glenmark and Ichnos take a collaborative leap to accelerate innovation in Cancer Treatment with their alliance 'Ichnos Glenmark Innovation'	31.01.
Glenmark Pharmaceuticals Limited Partners with Pfizer to Launch Abrocitinib in India	31.01.
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 for Multiple Geographies around the World	26.01.
Alphamab Oncology Unit, 3D Medicines Grants Glenmark Unit License to Commercialize Sarcoma Injectable	25.01.
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	23.01.
Glenmark Pharmaceuticals Limited Launches Biosimilar of the Popular Antidiabetic Drug, Liraglutide, for the First Time in India	03.01.
Glenmark Pharmaceuticals Introduces Anti-Diabetic Drug Liraglutide in India	03.01.
Glenmark Pharmaceuticals : is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India	03.01.
Glenmark Pharmaceuticals Swings to Loss in Fiscal Q2; Shares Slide 5%	14.11.
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	10.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Glenmark Pharmaceuticals Limited

Aktien

A0MU6U

INE935A01035

GLENMARK

Andere Sprachen

Filter